Please disable your adblock and script blockers to view this page

FDA Approved Biogen Alzheimer?s Drug Despite Some Staff Concerns


MembershipCustomer ServiceTools & FeaturesAdsMoreDow Jones Products

No matching tags

No matching tags

No matching tags

No matching tags

No matching tags

No matching tags

Positivity     14.00%   
   Negativity   86.00%
The New York Times
SOURCE: https://www.wsj.com/articles/fda-approved-biogen-alzheimers-drug-despite-some-staff-concerns-11624393800?mod=hp_lead_pos2
Write a review: The Wall Street Journal
Summary

The agency has faced criticism for approving the drug, Aduhelm, without clear proof it works

 As said here by Joseph Walker, Thomas M. Burton
The Wall Street Journal
Joseph Walker, Thomas M. Burton